Dr. Benjamin Kelmendi, MD
Claim this profileConnecticut Mental Health Center
Studies Obsessive-Compulsive Disorder
Studies Compulsive Personality Disorder
2 reported clinical trials
1 drug studied
Affiliated Hospitals
Clinical Trials Benjamin Kelmendi, MD is currently running
Psilocybin
for Obsessive-Compulsive Disorder
This trial tests if taking psilocybin pills can help people with OCD by changing how their brain processes thoughts and emotions. The study compares different amounts of psilocybin to see if it reduces OCD symptoms more effectively. Psilocybin is a naturally occurring substance that has shown promise in treating mood and substance use disorders.
Recruiting1 award Phase 17 criteria
Psilocybin
for Depression
Approximately 240 eligible adult participants (≥18 years old) who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for Major Depressive Disorder (MDD) will be enrolled. Participants will be randomly assigned to receive a single oral dose of Psilocybin 25 mg, Psilocybin 5 mg, or inactive placebo. The purpose of this study is to evaluate the efficacy, safety, and tolerability of Psilocybin 25 mg versus placebo in adults with MDD, as assessed by the difference between groups in change in depressive symptoms from Baseline to Day 43 post-dose, and to characterize the durability of initial treatment effect and subsequent response to optional Psilocybin 25 mg re-administration(s) during the 1-year Follow-up Period.
Recruiting1 award Phase 3
More about Benjamin Kelmendi, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Benjamin Kelmendi, MD has experience with
- Psilocybin
Breakdown of trials Benjamin Kelmendi, MD has run
Obsessive-Compulsive Disorder
Compulsive Personality Disorder
Depression
Major Depressive Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Kelmendi, MD specialize in?
Benjamin Kelmendi, MD focuses on Obsessive-Compulsive Disorder and Compulsive Personality Disorder. In particular, much of their work with Obsessive-Compulsive Disorder has involved treating patients, or patients who are undergoing treatment.
Is Benjamin Kelmendi, MD currently recruiting for clinical trials?
Yes, Benjamin Kelmendi, MD is currently recruiting for 2 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Kelmendi, MD has studied deeply?
Yes, Benjamin Kelmendi, MD has studied treatments such as Psilocybin.
What is the best way to schedule an appointment with Benjamin Kelmendi, MD?
Apply for one of the trials that Benjamin Kelmendi, MD is conducting.
What is the office address of Benjamin Kelmendi, MD?
The office of Benjamin Kelmendi, MD is located at: Connecticut Mental Health Center, New Haven, Connecticut 06519 United States. This is the address for their practice at the Connecticut Mental Health Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.